| NCT ID | NCT07439016 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Charles University, Czech Republic |
| Condition | Atrial Fibrillation (AF) |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-11-01 |
| Primary Completion | 2026-11-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2025-11-01 with a primary completion date of 2026-11-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A prospective study that investigates the changes in LA echocardiographic parameters after PFA for paroxysmal AF.
Eligibility Criteria
Inclusion Criteria: * Age ≥18 years * Paroxysmal AF in sinus rhythm at procedural onset Exclusion Criteria: * Persistent or long-standing AF * Prior atrial ablation * Significant valvular disease * A history of LAA closure
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07439016 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Atrial Fibrillation (AF). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07439016 currently recruiting?
Yes, NCT07439016 is actively recruiting participants. Contact the research team at marek.hozman@fnkv.cz for enrollment information.
Where is the NCT07439016 trial being conducted?
This trial is being conducted at Prague, Czechia.
Who is sponsoring the NCT07439016 clinical trial?
NCT07439016 is sponsored by Charles University, Czech Republic. The trial plans to enroll 50 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.